要查看或添加评论,请登录
Formiventos的更多文章
-
2025年2月21日
Novo regulamento da gest?o da disponibilidade do medicamento
Foram publicadas em Diário da República as novas delibera??es do Infarmed relativas à gest?o da disponibilidade e…
-
2025年2月7日
Forma??o, Altera??o e Revis?o Anual de PRE?OS de MEDICAMENTOS: “Forma??o muito enriquecedora sobre o tema”
Realizou-se mais uma edi??o da forma??o sobre a Forma??o, Altera??o e Revis?o Anual de PRE?OS de MEDICAMENTOS,: Um guia…
2
1 条评论 -
2025年2月7日
EU Cosmetics Deadlines – New Rules Effective 01 February 2025
EU Cosmetics Deadlines – New Rules Effective 01 February 2025 In early 2024, the EU announced new restrictions and bans…
1
-
2025年1月21日
PHARMA NEWS & TRENDS. Janeiro 2025
Boa leitura ! .-Considerations for Complying With 21 CFR 211.
-
2025年1月7日
PHARMA NEWS & TRENDS. Janeiro 2025
Gostaria de desejar-lhe um excelente 2025 com muita Saúde, Amor e Paz. Que seja um ano promissor para um futuro melhor!…
-
2024年12月16日
Revis?o do Regulamento Europeu relativo a altera??es aos termos da AIM
Publicado no site infarmed Circular Informativa N.o 106/CD/100.
1
-
2024年12月2日
PHARMA NEWS & TRENDS . Dezembro
Boa leitura ! Team-NB High level position on the regulatory framework for the medical devices sector EU Prosperity and…
1
-
2024年11月14日
DISPOSITIVOS MéDICOS 2024 : “Uma boa oportunidade para atualiza??o profissional “
Obrigado a todos os que participaram o dia 12 de novembro na forma??o DISPOSITIVOS MéDICOS : bajo o lema O MUST-KNOW…
5
-
2024年11月12日
AUDITORIA INTERNA da QUALIDADE : Forma??es para traduzir os requisitos de BPF em evidências de compliance no contexto de auditoria
Apresentamos-lhe 2 forma??es com uma abordagem específica da AUDITORIA DE QUALIDADE, para Capacitar profissionais a…
-
2024年10月28日
Forma??es Boas Práticas de Distribui??o 2024-2025
Formiventos é reconhecida por garantir experiências formativas exclusivas e de alta qualidade, com o melhor Mix de…
2
社区洞察
-
StatisticsHow do you distinguish between a placebo and an active treatment?
-
Market AccessHow do you monitor and manage the risks and uncertainties of patient access schemes?
-
Medical SalesWhat are the most common challenges in procuring medical products, and how can you overcome them?
-
Patient AdvocacyHow can you effectively resolve conflicts with pharmacists?
-
Research and Development (R&D)What are the steps to ensure your R&D lab is licensed and certified?
-
Emotional IntelligenceHow can you use EI to build better relationships with stakeholders during drug launches?
-
Healthcare ManagementHow do you use utilization management metrics to monitor prescription drug use?
-
Business ManagementWhat are the consequences of confirmation bias in clinical trials?
-
HealthcareHow can physicians be informed of a patient's medication history and potential drug interactions?
-
Outside SalesHow can you address client concerns about new drug side effects?
其他会员也浏览了
-
Application Route for Performance Studies Under the In Vitro Diagnostics Regulations in Northern Ireland
Sushvin Consultancy Services 5 个月 -
Highlights! Pharmedi Vietnam 2023, Konsung strikes on all fronts!
Jiangsu Konsung Bio-Medical Science & Technology Co.,Ltd. 1 年 -
MDCG 2021-4 has been updated with revision 1
mdi Europa GmbH 5 个月 -
MDCG 2022-3 updated
mdi Europa GmbH 2 个月 -
Team NB position paper on IVDR transfer agreement for surveillance
mdi Europa GmbH 5 个月 -
Michelle's Monday Minute: 22SEPT12
Michelle Rohrer 2 年 -
Guidance on safety reporting in performance studies
mdi Europa GmbH 10 个月 -
EU CTAG Dec24 Meeting Minutes released today
Pierre Mermet-Bouvier 3 周 -
PMPRB: A fork in the road
Wayne Critchley 4 年 -
FDA Office of the Chief Medical Officer released yesterday the Guidance planned to be published in 2025
Pierre Mermet-Bouvier 1 个月